Month: October 2018

Here is one that I had forgotten about. If you are having a cardio workout then your main motivation is to lose in fat.

If you wait at least an hour to eat after all of your cardio workouts then your body will start to burn of the glycogen in your muscles instead of having a nice supply of sugar in your blood to feed off of.

This is another reason why exercising, especially cardio are good to do first thing in the mornig before you have eaten anything to pop up your blood sugar.

If you are going to have a workout this would be the other way around as you need to have all the sugar in your blood that you can get to fuel your muscles to lift heavier s

EDIT…

Just wanted to add a quick extra to this and that is that if you are going to wait to eat after exercise the best amount of time that I have heard in the past is up to one hour.

The kind of food you would eat then I do not believe is different between a or a cardio workout and that is to eat a balanced meal but not a really large one.

Your body is healing after a workout and you would not want to tax the recovery by eating heavy foods that would slow you down

The blockbuster drug Vioxx was pulled from the market in the fall of 2004 after research showed that the painkiller doubled the risk of heart attack and stroke and that its use may have contributed to thousands of deaths in North America.
Now, a new Canadian study shows that the risk was even more dramatic because one in four of the heart attacks that occurred were within two weeks of the start of treatment.
“This demonstrates that cardiovascular risks from taking Vioxx may occur much earlier than previously believed,” said Linda Lévesque, an assistant professor in the department of community health and epidemiology at Queen’s University in Kingston.
At the same time, however, the research shows that additional risk virtually disappears within a month, meaning it is likely safe for long-term use.
The earlier data had suggested that the risk remained elevated for up to 18 months.
The research was published yesterday in the on-line edition of the Canadian Medical Association Journal.

Peter Liu, scientific director of the institute of circulatory and respiratory health of the Canadian Institutes for Health Research, said the study “adds important new information on how the Cox-2 inhibitors like Vioxx affect the heart.”
Rofecobix, which was sold under the brand name Vioxx, is one of a class of drugs known as Cyclo-oxygenase-2 inhibitors.
(The Cox enzyme has two forms in the body: Cox-1 protects the stomach lining from harsh acids and digestive chemicals, while Cox-2 is produced when joints are injured or damaged.)
One Cox-2 inhibitor, celecoxib, sold under the brand name Celebrex, is still available in Canada. Research has shown that Celebrex does not appear to increase cardiovascular risk in the same way as Vioxx and Bextra (valdecoxib), which was pulled from the Canadian market in April, 2005.
Data for the new study, conducted while Dr. Lévesque was a doctoral student at McGill University, were drawn from a database of 125,000 Quebec senior citizens who were prescribed painkillers between 1999 and 2002, and about one-quarter of whom were deemed “current users.”
Their average age was almost 79.
Researchers found that 239 current users of Vioxx and 287 current users of Celebrex suffered heart attacks — not an uncommon occurrence in this age group.
However, the risk of a heart attack rose sharply in the two weeks after first-time use of Vioxx, which was not the case with Celebrex.
An expert advisory panel, struck by Health Canada, had recommended last year that Vioxx be allowed to return to the market in Canada, but that has not occurred.
The panel also said that all anti-inflammatory drugs, including non-prescription painkillers such as ibuprofen, should have much stronger health warnings.
In the United States, the maker of Vioxx, Merck Co. Inc., has been fighting thousands of lawsuits related to the drug.